437 related articles for article (PubMed ID: 29094186)
1. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
2.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
3. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
[TBL] [Abstract][Full Text] [Related]
4. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
5. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
6. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
Eraña H; Charco JM; Di Bari MA; Díaz-Domínguez CM; López-Moreno R; Vidal E; González-Miranda E; Pérez-Castro MA; García-Martínez S; Bravo S; Fernández-Borges N; Geijo M; D'Agostino C; Garrido J; Bian J; König A; Uluca-Yazgi B; Sabate R; Khaychuk V; Vanni I; Telling GC; Heise H; Nonno R; Requena JR; Castilla J
PLoS Pathog; 2019 Oct; 15(10):e1008117. PubMed ID: 31644574
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Prion Selection and Adaptation.
Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
Ma J; Zhang J; Yan R
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
[TBL] [Abstract][Full Text] [Related]
9. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
10. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.
Cosseddu GM; Nonno R; Vaccari G; Bucalossi C; Fernandez-Borges N; Di Bari MA; Castilla J; Agrimi U
PLoS Pathog; 2011 Nov; 7(11):e1002370. PubMed ID: 22114554
[TBL] [Abstract][Full Text] [Related]
11. Ovine recombinant PrP as an inhibitor of ruminant prion propagation in vitro.
Workman RG; Maddison BC; Gough KC
Prion; 2017 Jul; 11(4):265-276. PubMed ID: 28665745
[TBL] [Abstract][Full Text] [Related]
12.
Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
mSphere; 2017; 2(1):. PubMed ID: 28144628
[TBL] [Abstract][Full Text] [Related]
13. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.
Kim JI; Cali I; Surewicz K; Kong Q; Raymond GJ; Atarashi R; Race B; Qing L; Gambetti P; Caughey B; Surewicz WK
J Biol Chem; 2010 May; 285(19):14083-7. PubMed ID: 20304915
[TBL] [Abstract][Full Text] [Related]
14. De novo generation of infectious prions in vitro produces a new disease phenotype.
Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
[TBL] [Abstract][Full Text] [Related]
15. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
16. The Prion Concept and Synthetic Prions.
Legname G; Moda F
Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
[TBL] [Abstract][Full Text] [Related]
17. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
18. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
19. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
20. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
